Our findings are also consistent with clinical epidemiological evidence that a loss-of-function polymorphism in the human P2X7 receptor has been associated with a reduced risk of ischaemic heart disease and ischaemic stroke.53 This evidence concerns the gene P2RX7 and heart disorder.